Prime Medicine (PRME) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free PRME Stock Alerts $5.61 -0.11 (-1.92%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePrime Medicine, Inc.: Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updatesfinanznachrichten.de - May 10 at 8:24 PMBuy Rating Affirmed for Prime Medicine, Inc. on Robust Preclinical Data and Prime Editing Technology Prospectsmarkets.businessinsider.com - May 10 at 8:24 PMPRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024investorplace.com - May 10 at 3:26 PMPrime Medicine GAAP EPS of -$0.44 beats by $0.03, revenue of $0.59M misses by $0.32Mmsn.com - May 10 at 8:26 AMPrime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updatesglobenewswire.com - May 10 at 8:00 AMJefferies Financial Group Reiterates Buy Rating for Prime Medicine (NYSE:PRME)americanbankingnews.com - May 9 at 4:48 AMPrime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)globenewswire.com - May 8 at 8:00 AMPrime Medicine's (PRME) "Buy" Rating Reiterated at Jefferies Financial Groupmarketbeat.com - May 7 at 11:51 AMPrime Medicine (NYSE:PRME) Stock Price Down 2.5%marketbeat.com - May 6 at 7:33 PM144,288 Shares in Prime Medicine, Inc. (NYSE:PRME) Bought by Vestmark Advisory Solutions Inc.marketbeat.com - May 6 at 10:18 AMPrime Medicine (NYSE:PRME) Stock Price Up 5.7%marketbeat.com - May 1 at 1:22 PMFDA clears Prime Medicine to begin gene therapy clinical testingmsn.com - April 29 at 6:58 PMPrime Medicine Shares Rise 13% After FDA Clears IND Applicationmarketwatch.com - April 29 at 1:58 PMPrime Medicine (NYSE:PRME) Shares Gap Up to $4.43marketbeat.com - April 29 at 12:11 PMPrime Medicine Gets FDA Clearance for PM359 IND Applicationmarketwatch.com - April 29 at 8:57 AMPrime Medicine Announces FDA Clearance Of IND Application For Pm359 - Quick Factsmarkets.businessinsider.com - April 29 at 8:57 AMPrime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)globenewswire.com - April 29 at 7:00 AMBuy Rating Affirmed for Prime Medicine, Inc. on Strong Preclinical Data and Promising Clinical Outlookmarkets.businessinsider.com - April 25 at 9:32 PMPrime Medicine (NYSE:PRME) Reaches New 12-Month Low at $4.32marketbeat.com - April 25 at 3:45 PMPrime Medicine's (PRME) "Outperform" Rating Reiterated at Wedbushmarketbeat.com - April 23 at 1:47 PMPrime Medicine (NYSE:PRME) Shares Up 8.8%marketbeat.com - April 23 at 1:23 PMPrime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetingsglobenewswire.com - April 23 at 8:00 AMBuy Rating Affirmed for Prime Medicine, Inc. on Groundbreaking Genetic Editing Platform and Strategic Progressmarkets.businessinsider.com - April 23 at 12:41 AMChardan Capital Initiates Coverage of Prime Medicine (PRME) with Buy Recommendationnasdaq.com - April 22 at 7:41 PMPrime Medicine (NYSE:PRME) Shares Gap Up to $4.51marketbeat.com - April 22 at 12:49 PMPrime Medicine (NYSE:PRME) Research Coverage Started at Chardan Capitalmarketbeat.com - April 22 at 8:22 AMPrime Medicine (NYSE:PRME) Stock Price Down 5.7%marketbeat.com - April 18 at 4:55 PMPrime Medicine (NYSE:PRME) Sets New 12-Month Low at $5.46marketbeat.com - April 15 at 2:49 PMPrime Medicine (NYSE:PRME) Trading Down 4.1%marketbeat.com - April 11 at 1:48 PMPrime Medicine, Inc. (NYSE:PRME) Stock Position Boosted by Vanguard Group Inc.marketbeat.com - April 11 at 4:11 AMTD Cowen initiates Prime Medicine stock with Buy on editing platformuk.investing.com - April 10 at 1:43 AMPrime Medicine (NYSE:PRME) Stock Price Up 5.4%marketbeat.com - April 8 at 2:30 PMPrime Medicine (NYSE:PRME) Now Covered by Analysts at TD Cowenmarketbeat.com - April 8 at 8:19 AMPrime Medicine (NYSE:PRME) Sets New 52-Week Low at $5.48marketbeat.com - April 5 at 12:21 PMPrime Medicine, Inc. to Post Q1 2024 Earnings of ($0.45) Per Share, Wedbush Forecasts (NYSE:PRME)marketbeat.com - April 5 at 8:06 AMPrime Medicine, Inc. (NYSE:PRME) Given Average Rating of "Moderate Buy" by Brokeragesmarketbeat.com - April 5 at 6:36 AMPrime Medicine (NYSE:PRME) Trading Down 8.1%marketbeat.com - April 2 at 5:45 PMPrime Medicine (NYSE:PRME) Earns Outperform Rating from Analysts at Wedbushmarketbeat.com - April 2 at 4:35 PMARK Investment Management LLC Has $27.81 Million Stock Holdings in Prime Medicine, Inc. (NYSE:PRME)marketbeat.com - March 28 at 6:39 AM2 Magnificent Growth Stocks With Room to Runfool.com - March 27 at 8:45 AMPrime Medicine (NYSE:PRME) Shares Gap Up to $6.87marketbeat.com - March 26 at 12:26 PMPrime Medicine (NYSE:PRME) Shares Down 6% marketbeat.com - March 18 at 11:55 AM13 Best Little-Known Perks You Can Get From Amazon Primecnet.com - March 15 at 7:42 PMGeron wins FDA AdCom backing for blood cancer drugmsn.com - March 14 at 6:12 PMShort-Squeeze Roulette: 3 Stocks That Could Leave Bears Begginginvestorplace.com - March 14 at 2:44 PMBuy Rating Justified: Prime Medicine’s Promising Clinical Prospects and Innovative Gene Editing Technology Poised for Growthmarkets.businessinsider.com - March 12 at 6:16 PMPrime Medicine (NYSE:PRME) Shares Down 3.9% marketbeat.com - March 12 at 1:24 PMBlinken to travel to Jamaica for CARICOM meeting on Haiti, US State Dept saysmsn.com - March 12 at 1:16 PMPrime Medicine, Inc. (NYSE:PRME) Receives Consensus Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - March 11 at 6:17 AMPrime Medicine (NYSE:PRME) Stock Price Down 6.6% on Analyst Downgrademarketbeat.com - March 5 at 3:18 PM Get Prime Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for PRME and its competitors with MarketBeat's FREE daily newsletter. Email Address The Crypto 9-5 Escape Plan (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide PRME Media Mentions By Week PRME Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRME News Sentiment▼0.360.52▲Average Medical News Sentiment PRME News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRME Articles This Week▼112▲PRME Articles Average Week Get Prime Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for PRME and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Novavax News HilleVax News Cabaletta Bio News Kyverna Therapeutics News Exscientia News Humacyte News Valneva News Allogene Therapeutics News ProKidney News Alector News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:PRME) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prime Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
